Cite
Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
MLA
Zewei Wang, et al. “Tumor-Infiltrating IL-17A+ Cells Determine Favorable Prognosis and Adjuvant Chemotherapeutic Response in Muscle-Invasive Bladder Cancer.” OncoImmunology, vol. 9, no. 1, Jan. 2020. EBSCOhost, https://doi.org/10.1080/2162402X.2020.1747332.
APA
Zewei Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Yu Zhu, Le Xu, Bo Dai, Li Liu, Jianming Guo, & Jiejie Xu. (2020). Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer. OncoImmunology, 9(1). https://doi.org/10.1080/2162402X.2020.1747332
Chicago
Zewei Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Ying Xiong, et al. 2020. “Tumor-Infiltrating IL-17A+ Cells Determine Favorable Prognosis and Adjuvant Chemotherapeutic Response in Muscle-Invasive Bladder Cancer.” OncoImmunology 9 (1). doi:10.1080/2162402X.2020.1747332.